Oleuropein treatment has caused an increase in the Bax/Bcl-2 ratio in lung cancer cells (A549) [43], breast cancer cells [44] and neuroblastoma cells (SH-SY5Y) [39], in each case activating the caspase cascade causing cells to undergo apoptosis. Here, BAX is linked to breast cancer.